Rozalski A, Brade L, Kosma P, Appelmelk B J, Krogmann C, Brade H
Division of Biochemical Microbiology, Institut für Experimentelle Biologie und Medizin, Borstel, Federal Republic of Germany.
Infect Immun. 1989 Sep;57(9):2645-52. doi: 10.1128/iai.57.9.2645-2652.1989.
Murine monoclonal and rabbit polyclonal antibodies raised against the lipopolysaccharides (LPS) of Re mutants of Salmonella minnesota, Proteus mirabilis, and Escherichia coli were serologically characterized. Using natural Re LPS and natural and synthetic partial structures thereof, representing the 3-deoxy-D-manno-2-octulosonic acid (KDO) or lipid A region or both, the epitope specificities of four monoclonal antibodies were defined. Clones 20 (immunoglobulin M [IgM]) and 25 (IgG3) recognize a terminal alpha-pyranosidically linked KDO monosaccharide residue and the alpha-2,4-linked KDO disaccharide, respectively, as the immunodominant group. Therefore, these two antibodies are core antibodies which do not require the presence of lipid A constituents for binding. The minimal structure enabling binding of clone 17 (IgG2b) is a pseudotetrasaccharide of the sequence alpha-KDO-(2----4)-alpha-KDO-(2----6)-beta-glucosamine-(1----6)- glucosaminitol with two amide-linked 3-hydroxytetradecanoic acid residues. The smallest structure with which clone 22 (IgG3) reacted was de-O-acylated Re LPS. Therefore, clones 17 and 22 are LPS antibodies requiring both the lipid A and the KDO region for binding. Phosphoryl residues of the lipid A moiety in Re LPS are dispensable for the reaction with clone 17, whereas they are necessary for that with clone 22. These four different antibody types were also detected in polyclonal rabbit antisera and could be distinguished from each other by absorption experiments. It was found that type 20 and 25 antibodies either were not present or were present only in small amounts and that the majority of the antibodies were of types 17 and 22. From these data, we conclude that the immunodominant structures of Re LPS comprise both the KDO and lipid A domains.
对针对明尼苏达沙门氏菌、奇异变形杆菌和大肠杆菌的Re突变体脂多糖(LPS)产生的鼠单克隆抗体和兔多克隆抗体进行了血清学表征。使用天然Re LPS及其天然和合成的部分结构,这些结构代表3-脱氧-D-甘露糖-2-辛酮糖酸(KDO)或脂质A区域或两者,确定了四种单克隆抗体的表位特异性。克隆20(免疫球蛋白M [IgM])和克隆25(IgG3)分别识别末端α-吡喃糖苷键连接的KDO单糖残基和α-2,4连接的KDO二糖作为免疫显性基团。因此,这两种抗体是核心抗体,结合时不需要脂质A成分的存在。使克隆17(IgG2b)结合的最小结构是序列为α-KDO-(2→4)-α-KDO-(2→6)-β-葡萄糖胺-(1→6)-葡糖胺醇的假四糖,带有两个酰胺连接的3-羟基十四烷酸残基。与克隆22(IgG3)反应的最小结构是脱O-酰基化的Re LPS。因此,克隆17和克隆22是LPS抗体,结合时需要脂质A和KDO区域。Re LPS中脂质A部分的磷酸化残基对于与克隆17的反应是可有可无的,而对于与克隆22的反应则是必需的。在兔多克隆抗血清中也检测到了这四种不同类型的抗体,并且可以通过吸收实验将它们彼此区分开来。发现20型和25型抗体要么不存在,要么仅少量存在,并且大多数抗体是17型和22型。根据这些数据,我们得出结论,Re LPS的免疫显性结构包括KDO和脂质A结构域。